Infectious Disease Diagnostics Market Projected to Reach $42.20 Billion by 2030

March 27 15:55 2026
Infectious Disease Diagnostics Market Projected to Reach $42.20 Billion by 2030
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs) – Global Forecast to 2030

According to MarketsandMarkets™, The report ” Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs)- Global Forecast to 2030″, is projected to reach USD 42.20 billion by 2030 from USD 26.58 billion in 2025, at a CAGR of 9.7% during the forecast period.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

 

Browse

  • 537 Market Data Tables
  • 59 Figures
  • 448 Pages and in-depth TOC on “Infectious Disease Diagnostics Market – Global Forecast to 2030”.

 

Some of the prominent key players are:

  • F. Hoffmann-La Roche Ltd. (Switzerland),
  • Abbott (US),
  • Danaher Corporation (US),
  • bioMérieux (France),
  • Thermo Fisher Scientific Inc. (US),
  • Siemens Healthineers AG (Germany),
  • Becton, Dickinson and Company (US),
  • Hologic, Inc. (US) and many more……

 

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Infectious Disease Diagnostics Market.

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

  • By product & service, the market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2024, the reagents, kits, and consumables segment accounted for the largest share of the market. The large share of this segment is attributed to the high volume of these products required for routine testing. Unlike instruments, consumable purchases are recurring, leading to consistent demand among end users.
  • The infectious disease diagnostics market has been segmented based on sample type into blood, serum, and plasma; urine; and other sample types. In 2024, the blood, serum, and plasma segment accounted for the largest share of the infectious disease diagnostics market, by sample type. These samples offer a rich & diverse source of diagnostic information for infectious diseases.
  • Based on technology, the infectious disease diagnostics market is broadly segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, DNA microarray, and other technologies. Immunodiagnostics growth is driven by rapid, reliable assays suitable for high-throughput and POC testing.
  • Based on clinical application, the infectious disease diagnostics market has been segmented into diagnostic and screening. Diagnostic testing is fueled by the need to confirm infections, guide treatment decisions, and monitor disease progression.
  • The infectious disease diagnostics market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the market. The region’s leadership is primarily driven by a well-established diagnostics landscape, with the US as the key contributor.

 

The growth of the infectious disease diagnostics market is primarily driven by the increasing incidence & prevalence of infectious diseases globally, coupled with the growing emphasis on early detection and timely treatment. The emergence of novel pathogens, recurring outbreaks, and the threat of antimicrobial resistance have further highlighted the need for accurate and rapid diagnostic solutions. Advancements in diagnostic technologies, including molecular & point-of-care platforms, have significantly improved test performance, accessibility, and turnaround times. Additionally, healthcare expenditure growth, diagnostic infrastructure expansion in emerging economies, and supportive government initiatives to strengthen disease surveillance are contributing to the market growth.

 

Related Reports:

Veterinary Infectious Disease Diagnostics Market – Global Forecast to 2030

Respiratory Care Devices Market – Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com